SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY M.M.O. Barros; A. Röth; W. Barcellini; T.H.A. Tvedt; Y. Miyakawa; D.J. Kuter; W. Hobbs; J. Su; X. Jiang; J.M. Arias; I.C. Weitz;